RU2404985C2 - Способ получения производных эпотилона, новые производные эпотилона, а также новые промежуточные соединения для реализации способа и способы их получения - Google Patents
Способ получения производных эпотилона, новые производные эпотилона, а также новые промежуточные соединения для реализации способа и способы их получения Download PDFInfo
- Publication number
- RU2404985C2 RU2404985C2 RU2008129613/04A RU2008129613A RU2404985C2 RU 2404985 C2 RU2404985 C2 RU 2404985C2 RU 2008129613/04 A RU2008129613/04 A RU 2008129613/04A RU 2008129613 A RU2008129613 A RU 2008129613A RU 2404985 C2 RU2404985 C2 RU 2404985C2
- Authority
- RU
- Russia
- Prior art keywords
- formula
- compounds
- compound
- heteroatoms
- alkyl
- Prior art date
Links
- 0 *[C@]1**CCC1 Chemical compound *[C@]1**CCC1 0.000 description 4
- YVDKYRTZNLERLU-HTWSVDAQSA-N CCC(C(C)(C)[C@H](CC(NC(CCC1)CC1C(C)(C)C(C)C)=O)OP)=O Chemical compound CCC(C(C)(C)[C@H](CC(NC(CCC1)CC1C(C)(C)C(C)C)=O)OP)=O YVDKYRTZNLERLU-HTWSVDAQSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0221312.2A GB0221312D0 (en) | 2002-09-13 | 2002-09-13 | Organic compounds |
| GB0221312.2 | 2002-09-13 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005110925/04A Division RU2343155C2 (ru) | 2002-09-13 | 2003-09-12 | Способ получения производных эпотилона |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2008129613A RU2008129613A (ru) | 2010-01-27 |
| RU2404985C2 true RU2404985C2 (ru) | 2010-11-27 |
Family
ID=9944042
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005110925/04A RU2343155C2 (ru) | 2002-09-13 | 2003-09-12 | Способ получения производных эпотилона |
| RU2008129613/04A RU2404985C2 (ru) | 2002-09-13 | 2003-09-12 | Способ получения производных эпотилона, новые производные эпотилона, а также новые промежуточные соединения для реализации способа и способы их получения |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2005110925/04A RU2343155C2 (ru) | 2002-09-13 | 2003-09-12 | Способ получения производных эпотилона |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7470792B2 (enExample) |
| EP (1) | EP1539768B1 (enExample) |
| JP (1) | JP4628102B2 (enExample) |
| KR (1) | KR20050042500A (enExample) |
| CN (1) | CN100522968C (enExample) |
| AR (1) | AR041231A1 (enExample) |
| AT (1) | ATE373663T1 (enExample) |
| AU (2) | AU2003267349B2 (enExample) |
| BR (1) | BR0314263A (enExample) |
| CA (1) | CA2497119C (enExample) |
| CY (1) | CY1107794T1 (enExample) |
| DE (1) | DE60316456T2 (enExample) |
| DK (1) | DK1539768T3 (enExample) |
| EC (1) | ECSP055652A (enExample) |
| ES (1) | ES2290489T3 (enExample) |
| GB (1) | GB0221312D0 (enExample) |
| IL (1) | IL166829A (enExample) |
| MX (1) | MXPA05002785A (enExample) |
| MY (1) | MY140442A (enExample) |
| NO (1) | NO20051794L (enExample) |
| NZ (1) | NZ538612A (enExample) |
| PE (1) | PE20050052A1 (enExample) |
| PL (1) | PL375039A1 (enExample) |
| PT (1) | PT1539768E (enExample) |
| RU (2) | RU2343155C2 (enExample) |
| SG (1) | SG155770A1 (enExample) |
| TW (1) | TWI289563B (enExample) |
| WO (1) | WO2004024735A2 (enExample) |
| ZA (1) | ZA200501008B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4579351B2 (ja) | 1996-12-03 | 2010-11-10 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | エポチロンの合成とその中間体及びその類似物並びにその使用 |
| US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
| CA2496477C (en) | 2002-08-23 | 2012-10-16 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| US20110300150A1 (en) | 2010-05-18 | 2011-12-08 | Scott Eliasof | Compositions and methods for treatment of autoimmune and other disease |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008849A1 (de) * | 1996-08-30 | 1998-03-05 | Novartis Aktiengesellschaft | Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens |
| WO1998025929A1 (en) * | 1996-12-13 | 1998-06-18 | Novartis Ag | Epothilone analogs |
| WO1999067252A2 (en) * | 1998-06-22 | 1999-12-29 | Novartis Ag | Epothilone derivatives and their synthesis and use |
| RU99120378A (ru) * | 1997-02-25 | 2001-07-20 | Гезелльшафт Фюр Биотехнологише Форшунг Мбх (Гбф) | Модифицированные в боковой цепи эпотилоны |
| WO2002030356A2 (en) * | 2000-10-13 | 2002-04-18 | The University Of Mississipi | Synthesis of epothilones and relates analogs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ337195A (en) * | 1997-02-25 | 2001-05-25 | Biotechnolog Forschung Gmbh | Epothilones with a modified side chain |
| US6498257B1 (en) * | 1998-04-21 | 2002-12-24 | Bristol-Myers Squibb Company | 2,3-olefinic epothilone derivatives |
| GB9810659D0 (en) * | 1998-05-18 | 1998-07-15 | Ciba Geigy Ag | Organic compounds |
| ES2207983T3 (es) * | 1998-12-22 | 2004-06-01 | Novartis Ag | Derivados de epotilona y su uso como agentes antitumorales. |
| AU6233600A (en) * | 1999-07-22 | 2001-02-13 | Schering Aktiengesellschaft | Process for the production of epothiolone b and derivatives as well as intermediate products for this process |
| US6593115B2 (en) * | 2000-03-24 | 2003-07-15 | Bristol-Myers Squibb Co. | Preparation of epothilone intermediates |
| IL166039A0 (en) * | 2002-07-31 | 2006-01-15 | Schering Ag | New effector conjugates process for their production and their pharmaceutical use |
-
2002
- 2002-09-13 GB GBGB0221312.2A patent/GB0221312D0/en not_active Ceased
-
2003
- 2003-09-11 AR ARP030103290A patent/AR041231A1/es active IP Right Grant
- 2003-09-11 PE PE2003000922A patent/PE20050052A1/es not_active Application Discontinuation
- 2003-09-12 AT AT03748015T patent/ATE373663T1/de active
- 2003-09-12 SG SG200701814-6A patent/SG155770A1/en unknown
- 2003-09-12 DK DK03748015T patent/DK1539768T3/da active
- 2003-09-12 PL PL03375039A patent/PL375039A1/xx not_active Application Discontinuation
- 2003-09-12 US US10/526,283 patent/US7470792B2/en not_active Expired - Fee Related
- 2003-09-12 EP EP03748015A patent/EP1539768B1/en not_active Expired - Lifetime
- 2003-09-12 RU RU2005110925/04A patent/RU2343155C2/ru not_active IP Right Cessation
- 2003-09-12 ES ES03748015T patent/ES2290489T3/es not_active Expired - Lifetime
- 2003-09-12 JP JP2004535499A patent/JP4628102B2/ja not_active Expired - Fee Related
- 2003-09-12 TW TW092125250A patent/TWI289563B/zh not_active IP Right Cessation
- 2003-09-12 NZ NZ538612A patent/NZ538612A/en not_active IP Right Cessation
- 2003-09-12 CA CA2497119A patent/CA2497119C/en not_active Expired - Fee Related
- 2003-09-12 CN CNB038215837A patent/CN100522968C/zh not_active Expired - Fee Related
- 2003-09-12 PT PT03748015T patent/PT1539768E/pt unknown
- 2003-09-12 KR KR1020057004237A patent/KR20050042500A/ko not_active Ceased
- 2003-09-12 MX MXPA05002785A patent/MXPA05002785A/es active IP Right Grant
- 2003-09-12 WO PCT/EP2003/010171 patent/WO2004024735A2/en not_active Ceased
- 2003-09-12 BR BR0314263-9A patent/BR0314263A/pt not_active IP Right Cessation
- 2003-09-12 DE DE60316456T patent/DE60316456T2/de not_active Expired - Lifetime
- 2003-09-12 AU AU2003267349A patent/AU2003267349B2/en not_active Ceased
- 2003-09-12 RU RU2008129613/04A patent/RU2404985C2/ru not_active IP Right Cessation
- 2003-09-13 MY MYPI20033494A patent/MY140442A/en unknown
-
2005
- 2005-02-03 ZA ZA200501008A patent/ZA200501008B/xx unknown
- 2005-02-10 IL IL166829A patent/IL166829A/en not_active IP Right Cessation
- 2005-03-09 EC EC2005005652A patent/ECSP055652A/es unknown
- 2005-04-12 NO NO20051794A patent/NO20051794L/no not_active Application Discontinuation
-
2007
- 2007-11-08 CY CY20071101447T patent/CY1107794T1/el unknown
-
2008
- 2008-08-01 AU AU2008203451A patent/AU2008203451A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008849A1 (de) * | 1996-08-30 | 1998-03-05 | Novartis Aktiengesellschaft | Verfahren zur herstellung von epothilonen und zwischenprodukte innerhalb des verfahrens |
| WO1998025929A1 (en) * | 1996-12-13 | 1998-06-18 | Novartis Ag | Epothilone analogs |
| RU99120378A (ru) * | 1997-02-25 | 2001-07-20 | Гезелльшафт Фюр Биотехнологише Форшунг Мбх (Гбф) | Модифицированные в боковой цепи эпотилоны |
| WO1999067252A2 (en) * | 1998-06-22 | 1999-12-29 | Novartis Ag | Epothilone derivatives and their synthesis and use |
| WO2002030356A2 (en) * | 2000-10-13 | 2002-04-18 | The University Of Mississipi | Synthesis of epothilones and relates analogs |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7407975B2 (en) | Epothilone derivatives, method for producing same and their pharmaceutical use | |
| US20040058969A1 (en) | Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use | |
| US7001916B1 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
| CA2425828A1 (en) | Synthesis of epothilones and related analogs | |
| EP1080082B1 (en) | Intermediates for the synthesis of epothilones and methods for their preparation | |
| RU2404985C2 (ru) | Способ получения производных эпотилона, новые производные эпотилона, а также новые промежуточные соединения для реализации способа и способы их получения | |
| KR20000075623A (ko) | 제약 화합물을 제조하기 위한 선택적 에폭시화 방법 | |
| HK1078853B (en) | A new process for the preparation of epothilone derivatives | |
| AU2004200948A1 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
| Adityawarman | Total Synthesis Of 8, 9-Dehydro-Epothilone C | |
| Haak | Total Synthesis Of 8, 9-Dehydro-Epothilone C | |
| DE19907480A1 (de) | Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung | |
| AU4438602A (en) | New epothilone derivatives, process for their production, and their pharmaceutical use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130913 |